Abstract

Antibiotic therapy is commonly prescribed empirically for prostatitis. It is important to use an agent with broad spectrum activity and preferential accumulation in prostatic fluid. So fluoroquinolones have become the standard of care for chronic bacterial prostatitis.
Management of CP/CPPS (chronic prostatitis/chronic pelvic pain syndrome) patients is still an enigma for the patient and the urologists as well. According to the best?evidence?based articles, a 4?week trial a of fluoroquinolone antibiotic for newly diagnosed, antibiotic?na?ve CP/CPPS men, but no further antibiotic therapy for CP/CPPS men with a more chronic condition who have failed antibiotics in the past. (Korean J UTII 2006;1:39-44)